Updated Jul. 27, 2011 at 12:09 p.m.
Cary, N.C. — The Food and Drug Administration says Cetero Research's lab in Houston, Texas, committed "system-wide failures" in data gathering. The agency also sends a letter to companies that worked with Cetero saying some bioanalytical data "between April 2005 and June 2010 in support of marketing applications may need to be repeated or confirmed."Copyright 2013 WRAL Tech Wire. All rights reserved.
Cary-based life sciences research firm in trouble with FDA
Post a comment
Print this blog postE-mail blog post
Share
Cary, N.C. — The Food and Drug Administration says Cetero Research's lab in Houston, Texas, committed "system-wide failures" in data gathering. The agency also sends a letter to companies that worked with Cetero saying some bioanalytical data "between April 2005 and June 2010 in support of marketing applications may need to be repeated or confirmed."Copyright 2013 WRAL Tech Wire. All rights reserved.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows
Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
Triangle politician tries to accelerate crowdfunding; bill passes first hurdle
ChannelAdvisor seeks $80M, sets share target price for IPO
IT job openings 28% below 2012 numbers, report shows















